Open AccessPossibilities of targeted therapy for myelofibrosis: Moscow experience
Author(s) -
Olga Vinogradova,
М. М. Панкрашкина,
Dzhariyat Shikhbabaeva,
Mikhail Chernikov,
A. L. Neverova,
V. L. Ivanova,
Е. А. Никитин,
E. V. Usikova,
В. В. Птушкин
Publication year - 2022
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2022-17-4-94-105
Subject(s) - medicine , myelofibrosis , ruxolitinib , clinical trial , life expectancy , polycythemia vera , quality of life (healthcare) , population , disease , myeloproliferative neoplasm , essential thrombocythemia , intensive care medicine , oncology , bone marrow , nursing , environmental health